individuals surviving until middle and older age, when CVD becomes manifest -the so-called demographic transition.
INTRODUCTION
Cardiovascular disease (CVD) is a growing cause of death and disability in South Africa and the rest of sub-Saharan Africa -partly as a result of the increasing prevalence of determinants and risk factors for CVD in these societies in transition. This process was dubbed "the epidemiological transition" by Omran:
(1) a concept further developed by Olshansky (2) and Pearson. (3) The epidemiological transition in turn, is predicated upon demographic and nutritional transitions occurring as a result of socio-economic development and increasing globalisation that alter the determinants and risk factors for CVD and hence the patterns of CVD.
In most African countries CVD is now the second commonest cause of death after infectious disease, accounting for 10% of total deaths (4) and it is estimated that this burden of CVD will double from 1990 to 2020.
THE EPIDEMIOLOGICAL TRANSITION
The "epidemiological transition" comprises of four stages shown in Table 1 .
Three main drivers fuel this epidemiological transition:
1. Declining infant and child mortality has lead to rapid demographic changes resulting in large increases in the number of South Africa is to ensure that the latter group, as they become progressively wealthier, do not enter stage III but pass rapidly through to stage IV. This can most effectively be achieved through health promotion including primary prevention, delivered at community and primary health care level, focussing on the 5 major risk factors for CVD of smoking, high blood pressure, bad diet (including high saturated and trans-saturated fats; as well as scanty fruit and vegetables), physical inactivity, and obesity.
African countries then face a double burden -of communicable diseases such as HIV and AIDS, TB and malaria; as well as CVD.
The high levels of morbidity and premature mortality from CVD place a particular strain on African countries whose health systems are already struggling to cope with epidemics of infectious disease, perinatal and maternal disease.
The situation is exacerbated by the fact that CVD in Africa tends to occur earlier in life, resulting in socio-economic hardship as the breadwinner in the family dies or is disabled. In African countries more than half of CVD deaths occur among people between 30 and 69 years of age, an age 5-10 years below the equivalent group in Europe and North America.
Furthermore, their predicament is only likely to worsen, because 
RHEUMATIC HEART DISEASE
In the 1980s, most of sub-Saharan Africa was in stage I of the epidemiological transition; and rheumatic heart disease (RHD)
accounted for 10% to 35% of hospital cardiac patients in subSaharan Africa (8) and up to 20% of cardiac deaths noted at autopsy. In Soweto, Johannesburg, the incidence of RHD among primary school children was 6.9 per 1 000; and in Ibadan, Nigeria, the incidence was 3 per 1 000 among children. (8) This is particularly tragic as RHD is completely preventable having been virtually eradicated in most high income countries over the past 50 years.
It is a disease of poverty, related to overcrowding, poor housing, and undernutrition and requires a multi-sectoral response for prevention and cure. It is caused by group A beta-haemolytic streptococci. The principal methods of control are primary and secondary prevention of streptococcal infection.
FETAL ORIGINS OF CARDIOVASCULAR DISEASE
Formerly CVD was seen as a disease of affl uence; but the reverse is in fact true. Poor socio-economic conditions in child- gestation, which leads to disproportionate fetal growth, programmes later coronary heart disease" and hypertension. (10) The highest risk of coronary heart disease is seen among individuals who were born small and became heavier during childhood, (11) so-called "catch-up growth".
EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE IN AFRICA
Epidemiological data on CVD in Africa is scanty and of poor quality and national vital registration is available in only 5% of Africa's 53 countries. (12) Verbal autopsy has been shown to be an economical and useful way of improving the quality of cause-of-death information when health workers have minimal training. (12) Sentinel surveillance has also proven useful in monitoring changes in CVD prevalence with disease surveys periodically conducted at sentinel sites that are broadly representative of the general population. Demographic health surveys are conducted in several African countries including South Africa. (13) The importance of CVD mortality in sub-Saharan African countries tends to be underestimated, because crude mortality rates are used. Age-standardised mortality ratios (Table 2 ) however, reveal that several African countries are in the throes of an epidemic of CVD -where those who survive infant deaths and infectious disease in young adulthood -proceed to experience mortality rates in middle and later life that are sometimes higher than for Scotland and Finland. (14) CORONARY HEART DISEASE 
The increase in coronary heart disease (CHD) in sub-Saharan
Africa is presumably because of the increasing prevalence among African populations of the classical risk factors for CHD: smoking, a diet high in saturated fat, hypertension, obesity, diabetes mellitus, and lack of physical exercise. In addition, life expectancy in subSaharan Africa has risen so that more people are exposed to these risk factors for long enough periods to cause CHD. A study of black African patients admitted to a coronary care unit with acute myocardial infarction between 1995 and 1996 showed high rates of smoking and hypertension among the patients compared with controls matched by age and sex. In patients with newly diagnosed cardiovascular disease (CVD) presenting to a tertiary-care centre (Chris Hani Baragwanath Hospital in Soweto, South Africa) the most common conditions among these patients were hypertension, heart failure, valvular heart disease, and coronary artery disease. Systemic hypertension is the commonest cause of heart failure among black Africans. Early detection and control of systemic hypertension should be more aggressively pursued.
The global INTERHEART study demonstrated that nine easily measured risk factors are associated with more than 90% of the risk of myocardial infarction.
DILATED CARDIOMYOPATHY
Dilated cardiomyopathy (DCM) resulting in congestive cardiac failure is surprisingly common in sub-Saharan Africa, accounting for up to 20% of cardiac cases in some regions. Occasionally the disease is familial with specifi c candidate genes recently identifi ed. (21) There may be a whole spectrum of causes of DCM, including genetic etiology, toxins, and vitamin or micronutrient defi ciency, such as selenium defi ciency. Dilated cardiomyopathy is often seen as a late complication of HIV infection. (22) 
ENDOMYOCARDIAL FIBROSIS
Endomyocardial fi brosis is the most common restrictive cardiomyopathy worldwide. The most common form was biventricular endomyocardial fi brosis (56%), followed by right-sided endomyocardial fi brosis (28%). The frequency of familial occurrence was high and 77% of cases were asymptomatic.
In temperate climates the disease is rare, presenting as Loeffl er's endocarditis, a syndrome with marked eosinophilia. Consequently it has been suggested that EMF may be caused by an eosinophilic response to fi lariasis or malaria.
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HIV DISEASE AND THE HEART
It is now evident that cardiac involvement in patients with HIV and AIDS is relatively common. The effects occur in three ways: by direct invasion; (25) through the effects of opportunistic infections as a result of AIDS; and as side-effects of the treatment of HIV disease with antiretrovirals, particularly due to the longer survival of patients infected with HIV.
People living with HIV and AIDS have evidence of cardiac involvement at post mortem (40%) and by echocardiography (25%). (22) However, fewer than 10% ever experience symptoms.
Cardiac involvement is the cause of death in only 1% to 2% of patients infected with HIV (24) but this may change as hundreds of thousands of Africans are initiated onto antiretroviral therapy, particularly protease inhibitors.
Dilated cardiomyopathy is a late manifestation of HIV disease and the mechanism may include myocarditis due to HIV itself or the defi ciencies of carnitine, selenium and thiamine that supervene in AIDS. This may therefore be exacerbated in Africa where malnutrition is already rife. Cardiotoxicity of some drugs such as zidovudine has also been described.
Coronary disease may occur as a result of the dyslipidaemia, glucose intolerance, increased levels of C peptide, and endothelial dysfunction associated with some antiretroviral drugs, particularly protease inhibitors and nucleoside reverse transcriptase inhibitors.
The incidence of diabetes is increased 3-fold in those on HAART.
The vessel involvement is frequently diffuse and circumferential along the whole artery. (25) Other mechanisms may include altered coagulation in HIV disease, as well as changed adhesion properties of vascular monocytes. Coronary event incidence rates of 5.5 per 1 000 patient-years in patients receiving HAART have been reported. (25) Myocardial infarction is the mode of presentation in up to 76% and cebrovascular events are also common. (25) HIV and AIDS also cause stroke, pulmonary embolism, tuber- 
Infective endocarditis is also common in HIV disease; though with the introduction of HAART the incidence declined from 20.6 to 6.6 per 1 000 patient years. (25) Patients living with HIV and AIDS may also suffer from the cardiac effects of the malignancies that commonly occur in AIDS, such as Kaposi' sarcoma and Hodgkin's lymphoma.
The prevalence of hypertension is increased 3-fold in patients on HAART (25) and the prevalence of pulmonary hyper-tension increased from 1 in 200 000 in the general population to 1 in 200. (25) CONGENITAL HEART DISEASE Children in Africa suffer from rheumatic heart disease and sicklecell. Congenital heart disease has prevalence of 2.0 per 1 000, with ventricular septal defect, atrial septal defect, patent ductus arteriosus, and Fallot's tetralogy making up 85% of the cases.
DYSRHYTHMIAS
Atrial fi brillation is the most common cardiac arrhythmia in South 9 70 years and older. In a cardiac clinic in Soweto, South Africa 33% of patients had some form of arrhythmia; and 7% had atrial fi brillation.
PERICARDIAL EFFUSIONS
A study carried out from 1989 to 1996 in the Republic of Congo found that 4.9% of patients with cardiovascular disease had nonrheumatic pericarditis with effusion. (28) Twenty-two percent were HIV positive. The principal cause of the pericarditis was tuberculosis, which accounted for about a quarter of the patients, all of whom were HIV positive.
URBAN RURAL DIFFERENCES
At the beginning of the twentieth century, high blood pressure was virtually nonexistent among indigenous Kenyans (29) and Ugandans, (8) but the reason may have been the lack of screening programs and access to care. From about 1975, high blood pressure became established, especially in urban centres. Rural-to-urban migration coupled with acculturation and modernisation trends have some relation to the development of high blood pressure, whose prevalence varies from 5% amongst rural African cohorts to 15% in urban areas. (30, 31) Among the Luo of Kenya, increasing blood pressure within months of migrating from the rural areas to the city has been recorded, with concomitant increases in their dietary sodium and declines in their dietary potassium. (29) In South Africa, even rural populations have high rates of noncommunicable disease, which accounted for 41% of deaths in those aged 50 and older in a rural demographic site in the eastern part of South Africa.
CONCLUSION
To date no evidence has been found that Africans have esoteric, genetically determined risk factors for CVD that differ from other populations in the world; nor do they appear to have special genetic traits that protect them from heart disease. It seems likely that the continuing socio-economic advance in many African countries over the next 50 years will be accompanied by the attendant increases in CVD that were seen in epidemiological transitions across the world over the past 50 years.
CHD and strokes share common determinants and risk factors and are more common in urban than rural areas. Any suggestion that people of black African descent are in some way immune from CVD has been dispelled by well-documented evidence from, among other countries, Cameroon, Caribbean countries, Mauritius, the Seychelles, South Africa, Tanzania, and the United States. In such countries CVD already accounts for between 15% and 40% of all deaths.
The challenge is to introduce primary and secondary prevention measures now, before the epidemic of CVD accelerates, particularly as such strategies may be more cost-effective than angioplasty and cardiac surgery in the cash-strapped economies of sub-Saharan Africa.
The costs of intersectoral, primary preventive measures to control CVD are likely to be much lower than those for acute, secondary care. As an example, the cost-effectiveness of introducing antitobacco legislation, and limiting the quantities of salt permitted in processed food. Such health promotion interventions should be coupled with primary health care systems delivering secondary prevention, treatment and care for CVD.
